Obesity drugmaker Novo Nordisk misses Q2 profit forecast
By Maggie FickLONDON (Reuters) -Novo Nordisk on Wednesday posted second-quarter operating profit below expectations, raised its 2024 sales forecast but…
Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs
When GLP-1 drugs for diabetes and weight loss, exploded onto the scene two years ago, patients scrambled to get their…
Makers of Ozempic Sued for ‘Downplaying’ Severe Side Effects
The makers of two popular but off-label weight loss drugs are now being sued over complications allegedly linked to their…
